Dr. Reddy's COO to retire; former Teva executive named as replacement

In This List

Blog

Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet

Blog

Insight Weekly: Stocks limp into 2023; GCC banks set for rebound; deep-sea mining faces pushback

Infographic

Infographic: The Big Picture 2023 Sustainability Outlook

Blog

The Big Picture for 2023: Assessing Investment Trends and the Impact of Investor Activism

29 Mar, 2018 | 09:48

Author Kshitiz Goliya
Theme Healthcare & Pharmaceuticals

India's Dr. Reddy's Laboratories Ltd. said its COO, Abhijit Mukherjee, will retire March 31.

Mukherjee, who served at the generic-drug maker for 15 years, will be replaced by Erez Israeli.

Israeli held several senior positions, including vice president of Asia operations and president and CEO of growth markets during his 23 years at Teva Pharmaceutical Industries Ltd.

He is also the former president and CEO of specialty chemicals-maker Enzymotec Ltd., which was acquired by Frutarom Industries Ltd. earlier this year.